Doripenem.

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Doripenem is a carbapenem antibiotic, a class of beta-lactam antimicrobials.
• It exhibits broad-spectrum activity against Gram-positive, Gram-negative, and anaerobic pathogens.
• Its spectrum is comparable to imipenem and meropenem.

Purpose of the Study:

• To evaluate the spectrum of activity of doripenem.
• To compare doripenem's efficacy against key hospital-acquired pathogens, including multidrug-resistant strains.
• To assess doripenem's potential role in empiric therapy.

Main Methods:

• Antimicrobial susceptibility testing against a range of clinically relevant pathogens.
• Comparative analysis of doripenem's in vitro activity against other carbapenems, particularly meropenem.
• Review of clinical data and guidelines for the use of antipseudomonal carbapenems.

Main Results:

• Doripenem demonstrates broad-spectrum activity, similar to meropenem.
• It may possess enhanced activity against certain Pseudomonas aeruginosa strains resistant to other carbapenems.
• Effective against common hospital pathogens like P. aeruginosa and Burkholderia cepacia.

Conclusions:

• Doripenem is a valuable parenteral antibiotic for treating infections caused by a wide array of bacteria.
• Its potential for improved activity against specific resistant pathogens warrants consideration in empiric treatment strategies.
• Combination therapy may be necessary for infections involving multidrug-resistant Gram-positive pathogens or P. aeruginosa.